These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 29031743

  • 1. Identifying clinically important difference on the Epworth Sleepiness Scale: results from a narcolepsy clinical trial of JZP-110.
    Scrima L, Emsellem HA, Becker PM, Ruoff C, Lankford A, Bream G, Khayrallah M, Lu Y, Black J.
    Sleep Med; 2017 Oct; 38():108-112. PubMed ID: 29031743
    [Abstract] [Full Text] [Related]

  • 2. Effect of Oral JZP-110 (ADX-N05) on Wakefulness and Sleepiness in Adults with Narcolepsy: A Phase 2b Study.
    Ruoff C, Swick TJ, Doekel R, Emsellem HA, Feldman NT, Rosenberg R, Bream G, Khayrallah MA, Lu Y, Black J.
    Sleep; 2016 Jul 01; 39(7):1379-87. PubMed ID: 27166238
    [Abstract] [Full Text] [Related]

  • 3. Effect of oral JZP-110 (ADX-N05) treatment on wakefulness and sleepiness in adults with narcolepsy.
    Bogan RK, Feldman N, Emsellem HA, Rosenberg R, Lu Y, Bream G, Khayrallah M, Lankford DA.
    Sleep Med; 2015 Sep 01; 16(9):1102-8. PubMed ID: 26298786
    [Abstract] [Full Text] [Related]

  • 4. A randomized study of solriamfetol for excessive sleepiness in narcolepsy.
    Thorpy MJ, Shapiro C, Mayer G, Corser BC, Emsellem H, Plazzi G, Chen D, Carter LP, Wang H, Lu Y, Black J, Dauvilliers Y.
    Ann Neurol; 2019 Mar 01; 85(3):359-370. PubMed ID: 30694576
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the effect of JZP-110 in patients with narcolepsy assessed using the Maintenance of Wakefulness Test censored to 20 minutes.
    Ruoff C, Bogan RK, Emsellem H, Feldman N, Lankford A, Bream G, Khayrallah M, Lu Y, Carter LP, Black J.
    Sleep Med; 2017 Jul 01; 35():12-16. PubMed ID: 28619176
    [Abstract] [Full Text] [Related]

  • 6. Long-term study of the safety and maintenance of efficacy of solriamfetol (JZP-110) in the treatment of excessive sleepiness in participants with narcolepsy or obstructive sleep apnea.
    Malhotra A, Shapiro C, Pepin JL, Hedner J, Ahmed M, Foldvary-Schaefer N, Strollo PJ, Mayer G, Sarmiento K, Baladi M, Chandler P, Lee L, Schwab R.
    Sleep; 2020 Feb 13; 43(2):. PubMed ID: 31691827
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinically relevant effects of solriamfetol on excessive daytime sleepiness: a posthoc analysis of the magnitude of change in clinical trials in adults with narcolepsy or obstructive sleep apnea.
    Rosenberg R, Baladi M, Bron M.
    J Clin Sleep Med; 2021 Apr 01; 17(4):711-717. PubMed ID: 33226332
    [Abstract] [Full Text] [Related]

  • 9. Solriamfetol for the Treatment of Excessive Sleepiness in OSA: A Placebo-Controlled Randomized Withdrawal Study.
    Strollo PJ, Hedner J, Collop N, Lorch DG, Chen D, Carter LP, Lu Y, Lee L, Black J, Pépin JL, Redline S, Tones 4 Study Investigators.
    Chest; 2019 Feb 01; 155(2):364-374. PubMed ID: 30471270
    [Abstract] [Full Text] [Related]

  • 10. Criteria for gauging response to sodium oxybate for narcolepsy.
    Steffen AD, Lai C, Weaver TE.
    J Sleep Res; 2018 Aug 01; 27(4):e12628. PubMed ID: 29205601
    [Abstract] [Full Text] [Related]

  • 11. Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate.
    Erman M, Emsellem H, Black J, Mori F, Mayer G.
    Sleep Med; 2017 Oct 01; 38():92-95. PubMed ID: 29031763
    [Abstract] [Full Text] [Related]

  • 12. Solriamfetol treatment of excessive daytime sleepiness in participants with narcolepsy or obstructive sleep apnea with a history of depression.
    Krystal AD, Benca RM, Rosenberg R, Schweitzer PK, Malhotra A, Babson K, Lee L, Bujanover S, Strohl KP.
    J Psychiatr Res; 2022 Nov 01; 155():202-210. PubMed ID: 36070638
    [Abstract] [Full Text] [Related]

  • 13. Measures of functional outcomes, work productivity, and quality of life from a randomized, phase 3 study of solriamfetol in participants with narcolepsy.
    Emsellem HA, Thorpy MJ, Lammers GJ, Shapiro CM, Mayer G, Plazzi G, Chen D, Carter LP, Villa KF, Lee L, Menno D, Black J, Dauvilliers Y.
    Sleep Med; 2020 Mar 01; 67():128-136. PubMed ID: 31926465
    [Abstract] [Full Text] [Related]

  • 14. Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea.
    Weaver TE, Menno DM, Bron M, Crosby RD, Morris S, Mathias SD.
    Sleep Breath; 2021 Sep 01; 25(3):1707-1715. PubMed ID: 33394323
    [Abstract] [Full Text] [Related]

  • 15. Narcolepsy Severity Scale-2 and Idiopathic Hypersomnia Severity Scale to better quantify symptoms severity and consequences in Narcolepsy type 2.
    Barateau L, Chenini S, Denis C, Lorber Q, Béziat S, Jaussent I, Dauvilliers Y.
    Sleep; 2024 May 10; 47(5):. PubMed ID: 38197577
    [Abstract] [Full Text] [Related]

  • 16. Comparing Treatment Effect Measurements in Narcolepsy: The Sustained Attention to Response Task, Epworth Sleepiness Scale and Maintenance of Wakefulness Test.
    van der Heide A, van Schie MK, Lammers GJ, Dauvilliers Y, Arnulf I, Mayer G, Bassetti CL, Ding CL, Lehert P, van Dijk JG.
    Sleep; 2015 Jul 01; 38(7):1051-8. PubMed ID: 25902810
    [Abstract] [Full Text] [Related]

  • 17. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J, Swick T, Bogan R, Lai C, Carter LP.
    Sleep Med; 2016 Aug 01; 24():57-62. PubMed ID: 27810187
    [Abstract] [Full Text] [Related]

  • 18. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial.
    Dauvilliers Y, Bassetti C, Lammers GJ, Arnulf I, Mayer G, Rodenbeck A, Lehert P, Ding CL, Lecomte JM, Schwartz JC, HARMONY I study group.
    Lancet Neurol; 2013 Nov 01; 12(11):1068-75. PubMed ID: 24107292
    [Abstract] [Full Text] [Related]

  • 19. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J, Houghton WC.
    Sleep; 2006 Jul 01; 29(7):939-46. PubMed ID: 16895262
    [Abstract] [Full Text] [Related]

  • 20. Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials.
    Meskill GJ, Davis CW, Zarycranski D, Doliba M, Schwartz JC, Dayno JM.
    CNS Drugs; 2022 Jan 01; 36(1):61-69. PubMed ID: 34935103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.